21 studies were found.

1.		Recruiting	Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; ...
2.		Recruiting	PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma Conditions: advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
3.		Recruiting	Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma Conditions: epithelial mesothelioma; localized malignant mesothelioma; advanced malignant mesothelioma
4.		Recruiting	Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma Conditions: advanced malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma
5.		Recruiting	EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer Conditions: malignant ascites; peritoneal cavity cancer; advanced malignant mesothelioma; localized malignant mesothelioma; recurrent malignant mesothelioma
6.		Recruiting	ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
7.		Recruiting	ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy Condition: Mesothelioma
8.		Recruiting	Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; perioperative/postoperative complications; Quality of Life
9.		Recruiting	Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Conditions: advanced malignant mesothelioma; recurrent malignant mesothelioma
10.		Recruiting	Experimental Drug SS1(dsFv)-PE38 to Treat Cancer Conditions: Mesothelioma; Ovarian Neoplasm; Squamous Cell Neoplasm
11.		Recruiting	Treatment of Peritoneal Cancer with Surgery, Perfused Heated Cisplatin, and Chemotherapy Conditions: Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal Neoplasm
12.		Recruiting	Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Patients with Pulmonary and Pleural Malignancies Conditions: Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma
13.		Recruiting	Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma Condition: localized malignant mesothelioma
14.		Recruiting	Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer Conditions: Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer
15.		Recruiting	Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Condition: Cancer
16.		Recruiting	Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors Conditions: female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
17.		Recruiting	Alanosine in Treating Patients With Cancer Conditions: Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma; thorax and respiratory cancer
18.		Recruiting	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Condition: Cancer
19.		Recruiting	Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors Condition: Cancer
20.		Recruiting	Investigating the Use of SS1(dsFv)-PE38 to Treat Advanced Malignancies Condition: Carcinoma
21.		Recruiting	Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer Conditions: Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer